IVF Hartmann Holding AG represents a strong commitment to innovation, excellence, and customer satisfaction. With a focus on the healthcare industry, the company places great value on delivering high-quality medical solutions and services. IVF Hartmann Holding AG prioritizes ethical business practices, maintaining strong relationships with stakeholders and ensuring the well-being of patients. The company's corporate philosophy revolves around continuous improvement, fostering a culture of collaboration and teamwork. IVF Hartmann Holding AG aims to contribute to the development of sustainable healthcare solutions, leveraging cutting-edge technology and industry expertise to drive long-term growth and success.

IVF Hartmann Holding AG is primarily present in Switzerland, Germany, Austria, France, and other European countries.

IVF Hartmann Holding AG, a leading company in the field of in vitro fertilization (IVF), has achieved several significant milestones. The company has successfully expanded its operations internationally, establishing a strong presence in key markets. IVF Hartmann Holding AG has also developed and introduced innovative technologies and solutions, revolutionizing the IVF industry. The company's dedication to research and development has led to breakthroughs in fertility treatment, improving success rates for couples seeking to conceive. IVF Hartmann Holding AG has consistently delivered exceptional quality care and support to patients, earning a reputation as a trusted and reliable partner in the fertility sector.

IVF Hartmann Holding AG is a renowned company specialized in medical devices, primarily focused on the field of in vitro fertilization (IVF). Founded in (year), the company has a rich history in providing innovative solutions to assist in the reproductive healthcare industry. With a strong commitment to quality and patient care, IVF Hartmann Holding AG has established itself as a trusted partner for clinics and fertility specialists worldwide. Their comprehensive portfolio includes pioneering technologies and tailor-made products, contributing to successful outcomes in assisted reproduction. Continuously striving for advancements, IVF Hartmann Holding AG remains a key player in the ever-evolving landscape of reproductive medicine.

The main competitors of IVF Hartmann Holding AG in the market include major healthcare companies such as Johnson & Johnson, Cardinal Health, and Medline Industries. These companies are also involved in the production and distribution of medical and healthcare products and services. IVF Hartmann Holding AG faces competition from these industry leaders, who have established strong market positions and extensive product portfolios.

IVF Hartmann Holding AG is primarily active in the healthcare industry.

The business model of IVF Hartmann Holding AG is focused on the manufacturing and distribution of medical and hygiene products. As a leading provider in the healthcare sector, IVF Hartmann offers a wide range of solutions including wound management, incontinence care, infection prevention, and surgical consumables. Their products cater to hospitals, clinics, long-term care facilities, and individuals worldwide. By emphasizing innovation, quality, and customer satisfaction, IVF Hartmann aims to improve patient care and enhance healthcare professionals' efficiency. With an extensive portfolio and a commitment to sustainable practices, IVF Hartmann Holding AG strives to be a trusted partner in the medical industry.

The P/E ratio cannot be calculated for IVF Hartmann Holding at the moment.

The P/S cannot be calculated for IVF Hartmann Holding currently.

The Quality Investing for IVF Hartmann Holding is 3/10.

The revenue cannot currently be calculated for IVF Hartmann Holding.

The profit cannot currently be calculated for IVF Hartmann Holding.

The IVF Hartmann Holding AG is a globally leading company in the field of medical consumables and services for the healthcare industry. The company offers a wide range of innovative products and services for hospitals, clinics, nursing homes, and medical practices. The various divisions of IVF Hartmann Holding AG include wound care, incontinence care, surgical supplies, sterilization systems, infection protection, and medication management. In the field of wound care, the company offers absorbing dressings, shaped wound dressings, hydrocolloid dressings, and foam dressings, for example. In incontinence care, products such as pads, diapers, and nursing aids are offered. The range of surgical supplies includes medical gloves, surgical clothing, as well as medical instruments and devices. For sterilization systems, the company offers innovative sterilization methods with high spore elimination, enabling efficient and safe sterilization of medical products. In the field of infection protection, the products include disinfectants, protective equipment, as well as reprocessing systems for the hygienic preparation of medical instruments. Medication management includes the documentation of medication administration and the packaging of medications in specialized dosage systems. The business model of IVF Hartmann Holding AG is based on a wide range of products, comprehensive service offerings, and a strong global presence. The company serves customers in over 50 countries and operates in Europe, Asia, and North America. A high level of innovation and close collaboration with customers and partners ensure continuous development of products and services. To ensure high quality standards, IVF Hartmann Holding AG relies on state-of-the-art production technologies and strict control and quality management processes. The company operates its own production facilities and research institutions and utilizes modern IT systems for process automation and logistics optimization. In addition to the sale of products, IVF Hartmann Holding AG also offers training and professional development programs for healthcare professionals. A team of experienced experts is available to customers for questions and problems, supporting them in the selection and application of products and services. Overall, IVF Hartmann Holding AG is an innovative company that successfully operates in the global market with a wide range of medical consumables and services. A high quality standard, a strong global presence, and close collaboration with customers and partners ensure optimal patient care and effective support for healthcare professionals.

IVF Hartmann Holding pays a dividend of 1.9 CHF distributed over payouts per year.

The dividend cannot currently be calculated for IVF Hartmann Holding or the company does not pay out a dividend.

The ISIN of IVF Hartmann Holding is CH0187624256.

The WKN of IVF Hartmann Holding is A1J1DQ.

The ticker of IVF Hartmann Holding is VBSN.SW.

Over the past 12 months, IVF Hartmann Holding paid a dividend of 3.2 CHF . This corresponds to a dividend yield of about 2.35 %. For the coming 12 months, IVF Hartmann Holding is expected to pay a dividend of 3.2 CHF.

The current dividend yield of IVF Hartmann Holding is 2.35 %.

IVF Hartmann Holding pays a quarterly dividend. This is distributed in the months of May, May, May, May.

IVF Hartmann Holding paid dividends every year for the past 12 years.

For the upcoming 12 months, dividends amounting to 3.2 CHF are expected. This corresponds to a dividend yield of 2.35 %.

IVF Hartmann Holding is assigned to the 'Health' sector.

To receive the latest dividend of IVF Hartmann Holding from 4/23/2025 amounting to 3.2 CHF, you needed to have the stock in your portfolio before the ex-date on 4/17/2025.

The last dividend was paid out on 4/23/2025.

In the year 2024, IVF Hartmann Holding distributed 2.5 CHF as dividends.

The dividends of IVF Hartmann Holding are distributed in CHF.